Beatriz Sanchez Alamo

Medicine and Dentistry

1. Age Groups 11%
2. ANCA Associated Vasculitis 50%
3. Biological Marker 16%
4. Cancer 29%
5. Cardiovascular Disease 12%
6. Chronic Kidney Disease 7%
7. Clinical Trial 16%
8. Cohort Analysis 5%
9. Comorbidity 16%
10. Cumulative Incidence 7%
11. Development 50%
12. Disease Assessment 16%
13. Early Diagnosis 7%
14. End Stage Renal Disease 21%
15. Follow up 11%
16. Glomerular Filtration Rate 5%
17. Glomerulonephritis 16%
18. Glomerulus 7%
19. Hazard Ratio 7%
20. Immunoassay 16%
21. Infection 7%
22. Kidney Function 50%
23. Kidney Graft 7%
24. Kidney Injury 7%
25. Kidney Transplantation 7%
26. Laboratory 5%
27. Low Platelet Count 5%
28. Male 5%
29. Observation 5%
30. Patient 50%
31. Patient Population 7%
32. Prognostic Factor 57%
33. Proportional Hazards Model 5%
34. Randomized Controlled Trial 14%
35. Recurrence Risk 16%
36. Relative Survival 5%
37. Renal Biopsy 7%
38. Renal Replacement Therapy 14%
39. Scoring System 14%
40. Survival Estimate 5%
41. Survival Rate 23%
42. Therapeutic Procedure 27%
43. Therapeutics 22%
44. Vasculitis 100%